OPKO Health (LTS:0KCS) Total Stockholders Equity: $1,184.2 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0KCS OPKO Health Inc LTS:0KCS
58 GF Score
Price $1.34
GF Value $1.12
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is OPKO Health Total Stockholders Equity?

OPKO Health LTS:0KCS -5.63% 58 Total Stockholders Equity is $1,184.2 Mil as of Jun. 2026. GuruFocus rates LTS:0KCS with a GF Score™ of 58/100 and a GF Value™ of $1.12 (Modestly Overvalued). The stock has 5 warning signs investors should review.

OPKO Health's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $1,184.2 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. OPKO Health's Book Value per Share for the quarter that ended in Jun. 2026 was $1.59. The ratio of a company's debt over equity can be used to measure how leveraged this company is. OPKO Health's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.34.

OPKO Health  (LTS:0KCS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

OPKO Health's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1184.166-0)/745.953
=1.59

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

OPKO Health's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(22.955 + 375.128) / 1184.166
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPKO Health Total Stockholders Equity Related Terms

OPKO Health Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for OPKO Health's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPKO Health Total Stockholders Equity Chart

OPKO Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,685.13 1,561.65 1,389.22 1,365.45 1,267.96

OPKO Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,296.90 1,305.49 1,267.96 1,204.61 1,184.17
LTS:0KCS
58GF Score
OPKO Health Inc LTS:0KCS
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $1,184.2 Mil mean?
OPKO Health (LTS:0KCS) has a Total Stockholders Equity of $1,184.2 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for OPKO Health and its competitors.
Is OPKO Health's Total Stockholders Equity too high?
OPKO Health's current Total Stockholders Equity is $1,184.2 Mil. Overall, OPKO Health has a GF Score™ of 58/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OPKO Health's Total Stockholders Equity compare to CSTL and FRNM?
OPKO Health's Total Stockholders Equity of $1,184.2 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Diagnostics & Research company?
A good Total Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for OPKO Health and its competitors. OPKO Health's current Total Stockholders Equity is $1,184.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPKO Health stock overvalued right now?
Based on GuruFocus' analysis, OPKO Health (LTS:0KCS) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.12, compared to a current price of $1.34 — trading 19.7% above its estimated fair value. The current Total Stockholders Equity is $1,184.2 Mil. OPKO Health's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For OPKO Health (LTS:0KCS), the current Total Stockholders Equity is $1,184.2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OPKO Health (LTS:0KCS) Overvalued in 2026?

Based on GuruFocus' analysis, OPKO Health stock appears to be overvalued. The current stock price of $1.34 is trading 19.7% above its estimated GF Value™ of $1.12. GuruFocus considers OPKO Health to be Modestly Overvalued.

Key valuation signals for LTS:0KCS:

  • Total Stockholders Equity: $1,184.2 Mil
  • GF Value™: $1.12 vs. price of $1.34 (19.7% above fair value)
  • GF Score™: 58/100 with 5 warning signs

No single metric tells the full story. See the LTS:0KCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OPKO Health Business Description

Address 4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
58GF Score

Get the complete analysis for LTS:0KCS

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.34
Price
$1.12
GF Value